@RLMiller_86 @danielgoyal It is actually happening through various channels and pharmaceutical company incentives to use drugs are widespread. https://t.co/wKqru9tJi1
Effects of pay-for-performance funding in primary care on mortality in the UK #HealthcareFunding https://t.co/MNMrnrD6k7 https://t.co/T4H9qNYkQF
@FormerKBT @nightmaree94 @paulhutcheon I presume you missed the link to The Lancet article within the previous linked article https://t.co/w2L4ZO16SY
@NOONE8376 @SkyNews (2) While £1.1bn is significant, it's a lot less than for example, the largest-ever public health experiment which cost £30 BILLION & did not lead to any statistically significant reduction in mortality rates Lancet report below.
@sophielouisecc Not as though the govt has ever wasted money before. The NHS ran the Quality and Outcomes Framework (QOF) public health experiment for 15 years. After £30 BILLION spent, the Lancet reported no statistically significant reduction in mortali
RT @AnkurFactorial: In 2016 @Andy_Ryan_dydx @narodmit et al published a retrospective diff-in-diff (using a synthetic UK control group) in…
RT @AnkurFactorial: In 2016 @Andy_Ryan_dydx @narodmit et al published a retrospective diff-in-diff (using a synthetic UK control group) in…
In 2016 @Andy_Ryan_dydx @narodmit et al published a retrospective diff-in-diff (using a synthetic UK control group) in @TheLancet and found a difference in age/sex-adjusted mortality from QOF-targeted conditions per 100,000 of -3.68 (95% CI: 0.80 to -8.16)
RT @FranckChaumeil: @Drmartyufml @le_Parisien Merci @CSMF_officiel pour RMO, ROSP et CPST vos cadeaux à la profession sont toujours appréci…
RT @FranckChaumeil: @Drmartyufml @le_Parisien Merci @CSMF_officiel pour RMO, ROSP et CPST vos cadeaux à la profession sont toujours appréci…
@Drmartyufml @le_Parisien Merci @CSMF_officiel pour RMO, ROSP et CPST vos cadeaux à la profession sont toujours appréciés à leur juste valeur et leur résultats aussi ! https://t.co/L4r11qdAOS https://t.co/FP2HzLk6Oh
@Michael_Chernew (2/2) @Andy_Ryan_dydx used "synthetic" UK of other countries for study of UK P4P program https://t.co/73lFkYOBWS
@PH_AdvocateEU @lolowi De plus , on pourrait trouver des fonds complémentaires en supprimant les paiements à la performance qui n’ont jamais prouvé améliorer la santé publique et introduisentune distorsion des relations patients/médecins. https://t.co/YiK2
RT @serdna975: ¿Debemos fomentar la dieta LC en DMT1? https://t.co/ChQZ5ZNOot En pleno siglo XXI… ¡NO se puede instaurar una práctica c…
RT @serdna975: ¿Debemos fomentar la dieta LC en DMT1? https://t.co/ChQZ5ZNOot En pleno siglo XXI… ¡NO se puede instaurar una práctica c…
RT @serdna975: ¿Debemos fomentar la dieta LC en DMT1? https://t.co/ChQZ5ZNOot En pleno siglo XXI… ¡NO se puede instaurar una práctica c…
RT @serdna975: ¿Debemos fomentar la dieta LC en DMT1? https://t.co/ChQZ5ZNOot En pleno siglo XXI… ¡NO se puede instaurar una práctica c…
RT @serdna975: ¿Debemos fomentar la dieta LC en DMT1? https://t.co/ChQZ5ZNOot En pleno siglo XXI… ¡NO se puede instaurar una práctica c…
¿Debemos fomentar la dieta LC en DMT1? https://t.co/ChQZ5ZNOot En pleno siglo XXI… ¡NO se puede instaurar una práctica clínica sin RCTs! ¡Ah, espera!, salvo que sea para endilgar más fármacos a nuestros (sus) mayores: QOF https://t.co/CnR9Jf10B9 htt
RT @vaglite: @DrJohnFa @DocArnica Les paiements au forfait entraînent une distorsion dans la relation médecin patient, n’améliorent pas la…
RT @vaglite: @DrJohnFa @DocArnica Les paiements au forfait entraînent une distorsion dans la relation médecin patient, n’améliorent pas la…
@DrJohnFa @DocArnica Les paiements au forfait entraînent une distorsion dans la relation médecin patient, n’améliorent pas la qualité des soins ni la santé publique. Il sont le moyen contrôlable de ne pas réévaluer la consultation à sa juste valeur... http
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
RT @FranckChaumeil: @Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigit…
@Zbigoudi29 @Egorafr @agnesbuzyn pour la ROSP le Lancet l' a démontré pour le TPG interrogez votre pharmacien ou Brigitte Dormont au choix ! https://t.co/x5Pt2OATmj
RT @FranckChaumeil: @delamare41 @LehmannDrC C'est pas en copiant le dernier de la classe que l'on remonte au classement ! P4P inefficace en…
RT @FranckChaumeil: @delamare41 @LehmannDrC C'est pas en copiant le dernier de la classe que l'on remonte au classement ! P4P inefficace en…
RT @FranckChaumeil: @delamare41 @LehmannDrC C'est pas en copiant le dernier de la classe que l'on remonte au classement ! P4P inefficace en…
RT @FranckChaumeil: @delamare41 @LehmannDrC C'est pas en copiant le dernier de la classe que l'on remonte au classement ! P4P inefficace en…
RT @FranckChaumeil: @delamare41 @LehmannDrC C'est pas en copiant le dernier de la classe que l'on remonte au classement ! P4P inefficace en…
@delamare41 @LehmannDrC C'est pas en copiant le dernier de la classe que l'on remonte au classement ! P4P inefficace en terme de prévention https://t.co/x5Pt2OATmj
RT @BalanCohen: Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https:/…
RT @BalanCohen: Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https:/…
RT @BalanCohen: Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https:/…
RT @BalanCohen: Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https:/…
RT @BalanCohen: Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https:/…
RT @BalanCohen: Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https:/…
RT @BalanCohen: Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https:/…
RT @BalanCohen: Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https:/…
RT @BalanCohen: Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https:/…
Pay-for-Performance in primary care in the UK not associated w/ mortality @Andy_Ryan_dydx @jdimick1 @andrewmibrahim https://t.co/vAeOXBLflP
RT @UM_CEHR: Pay-for-Performance in UK not associated with mortality https://t.co/pHrxYhTY9f @Andy_Ryan_dydx @jdimick1 @andrewmibrahim @UM_…
RT @UM_CEHR: Pay-for-Performance in UK not associated with mortality https://t.co/pHrxYhTY9f @Andy_Ryan_dydx @jdimick1 @andrewmibrahim @UM_…
RT @UM_CEHR: Pay-for-Performance in UK not associated with mortality https://t.co/pHrxYhTY9f @Andy_Ryan_dydx @jdimick1 @andrewmibrahim @UM_…
RT @UM_CEHR: Pay-for-Performance in UK not associated with mortality https://t.co/pHrxYhTY9f @Andy_Ryan_dydx @jdimick1 @andrewmibrahim @UM_…
RT @UM_CEHR: Pay-for-Performance in UK not associated with mortality https://t.co/pHrxYhTY9f @Andy_Ryan_dydx @jdimick1 @andrewmibrahim @UM_…
RT @UM_CEHR: Pay-for-Performance in UK not associated with mortality https://t.co/pHrxYhTY9f @Andy_Ryan_dydx @jdimick1 @andrewmibrahim @UM_…
RT @UM_CEHR: Pay-for-Performance in UK not associated with mortality https://t.co/pHrxYhTY9f @Andy_Ryan_dydx @jdimick1 @andrewmibrahim @UM_…
Pay-for-Performance in UK not associated with mortality https://t.co/pHrxYhTY9f @Andy_Ryan_dydx @jdimick1 @andrewmibrahim @UM_SPH @UM_IHPI https://t.co/APGmb581Hq
Long-term evidence for the effect of pay-for-performance in primary care on mortality in the UK: a population study https://t.co/JVq0AngCnn
Classmate citing @Andy_Ryan_dydx research right now: https://t.co/VoRHsFa2eH
Long-term evidence for the effect of pay-for-performance in primary care on mortality in the UK: a population study https://t.co/yw9YypOH2O
Long-term evidence for the effect of pay-for-performance in primary care on mortality in the UK: a population study https://t.co/vM2t5QR3NE
RT @glassmanamanda: Can this study design answer question on the effect of pay-for-performance in primary care on mortality in the UK? http…
Can this study design answer question on the effect of pay-for-performance in primary care on mortality in the UK? https://t.co/1aSUao4EuL
Long-term evidence pay-for-performance on #mortality in the UK: Lancet What about #morbidity? https://t.co/UDVOXnJXWr
Effect of pay-for-performance in primary care on mortality in the UK: a population study @thelancet https://t.co/OWysVORNUy
RT @Dr_A_Rashid: "introduction of the QOF in the UK was not significantly associated with changes in population mortality." https://t.co/9H…
RT @RogueRad: Were pay for performance a drug or device FDA would reject it in 3 minutes https://t.co/Qj6F2TWSyj
RT @RogueRad: Were pay for performance a drug or device FDA would reject it in 3 minutes https://t.co/Qj6F2TWSyj
Were pay for performance a drug or device FDA would reject it in 3 minutes https://t.co/Qj6F2TWSyj
RT @TheLancet: Pay-for-performance in primary care in the uk, and the effect on mortality https://t.co/U34gQ1Uv4V https://t.co/RJ4TiiZBx2
RT @Dr_A_Rashid: "introduction of the QOF in the UK was not significantly associated with changes in population mortality." https://t.co/9H…
RT @Dr_A_Rashid: "introduction of the QOF in the UK was not significantly associated with changes in population mortality." https://t.co/9H…
RT @Dr_A_Rashid: "introduction of the QOF in the UK was not significantly associated with changes in population mortality." https://t.co/9H…
RT @Dr_A_Rashid: "introduction of the QOF in the UK was not significantly associated with changes in population mortality." https://t.co/9H…
RT @Dr_A_Rashid: "introduction of the QOF in the UK was not significantly associated with changes in population mortality." https://t.co/9H…
"introduction of the QOF in the UK was not significantly associated with changes in population mortality." https://t.co/9HmabSVcib
RT @TheLancet: Pay-for-performance in primary care in the uk, and the effect on mortality https://t.co/U34gQ1Uv4V https://t.co/RJ4TiiZBx2
RT @TheLancet: Pay-for-performance in primary care in the uk, and the effect on mortality https://t.co/U34gQ1Uv4V https://t.co/RJ4TiiZBx2
RT @TheLancet: Pay-for-performance in primary care in the uk, and the effect on mortality https://t.co/U34gQ1Uv4V https://t.co/RJ4TiiZBx2
RT @TheLancet: Pay-for-performance in primary care in the uk, and the effect on mortality https://t.co/U34gQ1Uv4V https://t.co/RJ4TiiZBx2
RT @TheLancet: Pay-for-performance in primary care in the uk, and the effect on mortality https://t.co/U34gQ1Uv4V https://t.co/RJ4TiiZBx2
RT @TheLancet: Pay-for-performance in primary care in the uk, and the effect on mortality https://t.co/U34gQ1Uv4V https://t.co/RJ4TiiZBx2
RT @TheLancet: Pay-for-performance in primary care in the uk, and the effect on mortality https://t.co/U34gQ1Uv4V https://t.co/RJ4TiiZBx2
RT @TheLancet: Pay-for-performance in primary care in the uk, and the effect on mortality https://t.co/U34gQ1Uv4V https://t.co/RJ4TiiZBx2
Study: @NHSEngland $9B pay-for-performance program did not improve life expectancy; no comment of quality of life https://t.co/QpsYGzjwoJ
RT @ipsosante: selon le #Lancet impact non significatif de la #P4P sur mortalité au #UK https://t.co/5RuqnnwP9J #ROSP cc @cgep7 @HervePicar…